未找到相关数据
Peginterferon alfa-2a (40 KD) (pegasys) in combination with ribavirin (RBV): Efficacy and safety results from a phase III, randomized, double-blind, multicentre study examining effect of duration of treatment and RBV dose
被引：86
作者：
Hadziyannis, SJ
Cheinquer, H
Morgan, T
Diago, M
Jensen, DM
Sette, H
Ramadori, G
Bodenheimer, HC
Marcellin, P
Lee, SD
Roberts, PJ
Ackrill, AM
机构：
[1] Hippokratio Gen Hosp, Athens, Greece
[2] Univ Fed Rio Grande Sul, Porto Alegre, RS, Brazil
[3] Vet Adm Med Ctr, Long Beach, CA 90822 USA
[4] Rush Presbyterian St Lukes Med Ctr, Chicago, IL USA
[5] Mt Sinai Hosp, Mt Sinai Sch Med, New York, NY 10029 USA
[6] Inst Infectol Emilio Ribas, Sao Paulo, Brazil
[7] Gen Hosp, Valencia, Spain
[8] Univ Klin Gottingen, Gottingen, Germany
[9] Hop Beaujon, Clichy, France
[10] Taipei Vet Gen Hosp, Taipei, Taiwan
[11] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
关键词：
D O I：
10.1016/S0168-8278(02)80001-0
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1
引用
收藏
页码：3 / 3
页数：1
相关论文